Monday, June 13, 2016

The Sole Support In The Developed World
Has Been Monetary Policy
"In the absence of pro-growth policies on the fiscal side, the sole support in the developed world has been monetary policy. There’s been a more or less universally practiced set of monetary policies consisting of zero and now negative interest rates and so-called quantitative easing — various forms of asset buying. It started out as all bond buying, but now it’s leaked into equities. The result of all that — I call it monetary extremism — is that the economies have held up and had some growth, but that growth has been tepid, with the biggest gains going to those who own financial assets while wage growth has been stagnant.
The cure for the crisis — for the debt crisis, the financial crisis — has been deemed by the developed world governments to be more debt. There has not been a deleveraging ..  I think it’s a very dangerous time in the financial markets."
- Paul Singer
LINK HERE to the article

1 comment:

Anonymous said...

Stem Cell MS Patients Lead Normal Life Thanks To aHSCT Procedure June 13, 2016

People with MS who were involved in a long-term clinical trial are out and about enjoying a full and normal life with no signs of the disease. This follows their recovery from the stem cell transplants involving aggressive chemotherapy, or aHSCT as the procedure is known.

Results of the clinical study reached major news sources, including Multiple Sclerosis News Today on Friday after first being unveiled in The Lancet.

The 24 multiple sclerosis patients recruited for the trial were severely disabled but, with the exception of one who died, are now walking, working, kayaking, and skiing.

The trial is the first in the world to show complete long-term stopping of relapses of the debilitating disease and formation of new brain lesions. It used the Autologous Hematopoietic Stem Cell Transplantation (aHSCT) method with strong chemotherapy drugs to kill off the patients’ immune systems before rebooting them with their own heathy stem cells.